Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study

Authors

  • Libni J. Eapen The Ottawa Hospital Cancer Centre
  • Edward Jones BC Cancer Agency
  • Wassim Kassouf McGill University Montreal General Hospital
  • Carole Lambert Notre-Dame University
  • Scott C. Morgan University of Ottawa The Ottawa Hospital Cancer Centre
  • Madeleine Moussa Queen's University London Regional Cancer Centre
  • Robert Nam Odette Cancer Centre
  • Matthew Parliament Cross Cancer Institute
  • Laurie Russell Cross Cancer Institute
  • Fred Saad Notre Dame University Montreal
  • D. Robert Siemens Queen's University Kingston
  • Luis Souhami McGill University Montreal
  • Ewa Szumacher Odette Cancer Centre
  • Scott Tyldesley BC Cancer Agency
  • Yan Xu University of Ottawa Ottawa Hospital Cancer Centre
  • Ingrid Zbieranowski
  • Rodney H. Breau University of Ottawa
  • Eric Belanger University of Ottawa
  • Peter Black BC Cancer Agency
  • Eric Estey Cross Cancer Institute
  • Julie Bowan Sudbury Cancer Centre
  • Bishwajit Bora Sudbury Cancer Centre
  • Michael Brundage Kingston Cancer Centre
  • Peter Chung PMH
  • Neil Fleshner PMH
  • Andrew Evans PMH
  • Glenn Bauman London Cancer Centre
  • Jonathan Izawa London Cancer Centre
  • Chris Davidson Queen's University, Kingston
  • Fadi Brimo McGill University Montreal General Hospital

DOI:

https://doi.org/10.5489/cuaj.3456

Abstract

Introduction: We aimed to enumerate the rate of pelvic recurrence following radical cystectomy at university-affiliated hospitals in Canada.

Methods: Canadian, university-affiliated hospitals were invited to participate. They were asked to identify the first 10 consecutive patients undergoing radical cystectomy starting January 1, 2005, who had urothelial carcinoma stages pT3/T4 N0-2 M0. The first 10 consecutive cases starting January 1, 2005 who met these criteria were the patients submitted by that institution with information regarding tumour stage, age, number of nodes removed, and last known clinical status in regard to recurrence and patterns of failure.

Results: Of the 111 patients, 80% had pT3 and 20% pT4 disease, with 62% being node-negative, 14% pN1, and 27% pN2; 57% had 10 or more nodes removed. Cumulative incidence of pelvic relapse was 40% among the entire group

Conclusions: This review demonstrates a high rate of pelvic tumour recurrence following radical cystectomy for pT3/T4 urothelial cancer.

Downloads

Download data is not yet available.

Author Biography

Libni J. Eapen, The Ottawa Hospital Cancer Centre

Radiation Oncologist

Downloads

Published

2016-04-18

How to Cite

Eapen, L. J., Jones, E., Kassouf, W., Lambert, C., Morgan, S. C., Moussa, M., Nam, R., Parliament, M., Russell, L., Saad, F., Siemens, D. R., Souhami, L., Szumacher, E., Tyldesley, S., Xu, Y., Zbieranowski, I., Breau, R. H., Belanger, E., Black, P., Estey, E., Bowan, J., Bora, B., Brundage, M., Chung, P., Fleshner, N., Evans, A., Bauman, G., Izawa, J., Davidson, C., & Brimo, F. (2016). Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. Canadian Urological Association Journal, 10(3-4), 90–4. https://doi.org/10.5489/cuaj.3456

Issue

Section

Original Research